CClinicalTrials.gg
Status unknownNCT01917253Long&shortUpdated Aug 6, 2013

Standard Length Catheters vs Long Catheters in Peripheral Vein Cannulation.

An interventional study of Standard Device for peripheral vein cannulation and Long Catheters for peripheral vein cannulation in Complications, sponsored by ASL TO2 Torino. Status unknown at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-08-06.

Sponsored by ASL TO2 Torino · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2013), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
220
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The Long and Short is a prospective, randomized, controlled, open label trial to test the complications of different device for peripheral vein cannulation, standard length (about 5 cm in length) and long catheter (about 12 cm in length), inserted with Seldinger technique.

Read the detailed description

The trial will compare the main complications: infiltration rate, phlebitis rate, occlusion and/or dislocation rate, thrombosis rate, number of percutaneous sticks, successful cannulation.

Will be made for a cost analysis.

02

Conditions studied

  • Complications

Keywords

  • infiltration, phlebitis, occlusion, thrombosis
03

In context

Lead sponsor

This is the only study on the registry with ASL TO2 Torino as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • adult patients
  • infusional therapy more than 72 hours

Exclusion criteria

Exclusion Criteria:

  • need for central venous catheter
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
220 participants (estimated)

Study arms

  • Experimental
    standard length catheter

    Standard Device for peripheral vein cannulation

    Device: Standard Device for peripheral vein cannulation

  • Experimental
    Long catheter

    Standard Device for peripheral vein cannulation

    Device: Long Catheters for peripheral vein cannulation

Interventions

  • DeviceStandard Device for peripheral vein cannulation
  • DeviceLong Catheters for peripheral vein cannulation
06

What researchers measure

Primary outcomes

  1. complications rate

    Time frame: 3 days

07

Study locations

1 of 1 sites recruiting
  • MECAU-Maria Vittoria Hospital
    Torino, 10141, Italy
    • Piero Riva, MD · Contact · +39 011 439
    • Piero Riva, MD · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01917253
Lead sponsor
ASL TO2 Torino
Responsible party
Tiziana De Prospo (Nurse, ASL TO2 Torino) — Principal investigator
First posted
Aug 6, 2013
Start date
Sep 2013
Primary completion
Oct 2013 (estimated)
Completion
Dec 2013 (estimated)
Last update
Aug 6, 2013

Study contacts

Tiziana De Prospo
Contact
tiziana.deprospo@aslto2.piemonte.it
+39 011 439 ext. 5739
Piero Riva, MD
principal investigator · ASLTO2- MECAU- Maria Vittoria Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion